New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST) [Yahoo! Finance]
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight rating, reflecting confidence in the company's margin progress and anticipated performance in the life sciences tools sector. This follows an Overweight initiation on November 3, 2025, by Stephens with a $41 price target, citing Twist Bioscience (NASDAQ: TWST)'s proprietary silicon-based DNA synthesis platform as a competitive advantage in synthetic biology and research markets. Strategic product launches have reinforced investor interest. On December 4, 2025, TWST introduced research-grade Plasmid DNA Preps designed to support pre-clinical nucleic acid therapeutics research with animal origin-free and transfection-grade options, positioning the company as a more integral supplier for biotech and pharmaceutical discovery workflows. Twist Bioscience (NASDAQ: TWST) is a biotechnology company that has developed a proprietary silicon-based DNA synthesis plat
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience to Present at J.P. Morgan 2026 Healthcare ConferenceBusiness Wire
- Twist Bioscience (NASDAQ:TWST) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their RightsBusiness Wire
- Atlas Data Storage Announces Eon 100 Synthetic DNA Storage [Forbes]Forbes
- Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]Yahoo! Finance
TWST
Earnings
- 11/14/25 - Miss
TWST
Sec Filings
- 12/22/25 - Form 144
- 12/22/25 - Form 144
- 12/22/25 - Form 144
- TWST's page on the SEC website